ARCHIVES

DeVita Defends CHP Awards, Says Program Has High Priority

This article is from The Cancer Letter archive.

Vol. 06 No. 35 | September 5, 1980

Download PDF Visit The Full Archive

Related Articles

NCCS Networker Volume 5 Issue 3, Summer 1991

June 13, 1991

Phase III Vaccine Trial Fails To Improve Overall Survival

October 25, 2013

Benefit Seen In Novel Drug That Treats Gleevec Resistance

April 29, 2005

No Evidence Of Fraud Found In NCI Audit Of NSABP Trials

April 29, 1994

More Debate Due On Organ Site Program; First Round Reviewed By DRG “Slaughtered”

January 28, 1983

Learning From Europeans, U.S. Oncologists Consider Role For Oxaliplatin, 5-FU Infusion

May 31, 2002